Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Incannex Healthcare stock

Learn how to easily invest in Incannex Healthcare stock.

Incannex Healthcare Ltd ADR is a drug manufacturers-specialty & generic business based in the US. Incannex Healthcare shares (IXHL) are listed on the NASDAQ and all prices are listed in US Dollars.

How to buy shares in Incannex Healthcare

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – IXHL – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

Incannex Healthcare stock price (NASDAQ: IXHL)

Use our graph to track the performance of IXHL stocks over time.

Incannex Healthcare shares at a glance

Information last updated 2022-09-22.
Latest market close$4.35
52-week range$3.26 - $35.50
50-day moving average $4.42
200-day moving average $6.80
Wall St. target priceN/A
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-0.01

Buy Incannex Healthcare shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 7 of 7
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, ETFs, Cryptocurrency
$0
$0
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
eToro
Stocks, ETFs, Cryptocurrency
$0
$10
8%-12% of your deposit
when you sign up and deposit at least $50. T&Cs apply.
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, TN, and HI.
Public
Stocks, ETFs, Cryptocurrency
$0
$0
Receive a free stock slice worth between $3–$300
when you sign up for an account and deposit at least $20.
Commission-free trading in stocks and ETFs with a social networking twist.
Tastyworks
Stocks, Options, ETFs, Cryptocurrency
$0
$0
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0
$0
$125 - $625
when you open and fund an account with $25,000 - $250,000+
INVESTMENT AND INSURANCE PRODUCTS ARE: NOT A DEPOSIT • NOT FDIC INSURED • NO BANK GUARANTEE • MAY LOSE VALUE
Robinhood
Stocks, Options, ETFs, Cryptocurrency
$0
$0
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 3% interest on uninvested cash in your account with Robinhood Gold.
Tradier
Stocks, Options, ETFs
$0
$0
N/A
Customize your trade platform or build your own Deep tools, charts and screens Analyzers to help you study before you trade
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Incannex Healthcare stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Incannex Healthcare price performance over time

Historical closes compared with the close of $4.35 from 2022-09-28

1 week (2022-09-22) -10.12%
1 month (2022-08-29) 2.59%
3 months (2022-06-29) 11.25%
6 months (2022-03-29) -54.21%
1 year (2021-09-25) N/A
2 years (2020-09-25) N/A
3 years (2019-09-25) N/A
5 years (2017-09-25) N/A

Incannex Healthcare financials

Revenue TTM $782,383
Gross profit TTM $776,045
Return on assets TTM -30.06%
Return on equity TTM -67.07%
Profit margin 0%
Book value $0.70
Market capitalisation $279.5 million

TTM: trailing 12 months

Incannex Healthcare share dividends

We're not expecting Incannex Healthcare to pay a dividend over the next 12 months.

You may also wish to consider:

Incannex Healthcare share price volatility

Over the last 12 months, Incannex Healthcare's shares have ranged in value from as little as $3.26 up to $35.5. A popular way to gauge a stock's volatility is its "beta".

IXHL.US volatility(beta: 2.39)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Incannex Healthcare's is 2.385. This would suggest that Incannex Healthcare's shares are significantly more volatile than the average for this exchange and represent a higher risk.

To put Incannex Healthcare's beta into context you can compare it against those of similar companies.

Incannex Healthcare overview

Incannex Healthcare Limited engages in the research, development, and sale of medicinal cannabinoid and psychedelic pharmaceutical products and therapies in Australia. It offers APIRx-1801, an ultrapure tetrahydrocannabinol; APIRx-1802, an ultrapure CBD; and APIRx-1803, an ultrapure cannabigerol. The company also develops IHL-42X, which has completed Phase IIa clinical trial for obstructive sleep apnea; Psi-GAD that is in Phase IIa clinical trial for generalized anxiety disorder; MedChew Dronabinol, which has completed Phase Ia clinical trial for nausea and vomiting in chemotherapy; CanChew Plus that has completed Phase IIa clinical trial for irritable bowel syndrome; APIRx-1601, which has completed Phase IIa clinical trial for vitiligo; APIRx-1602 that has completed Phase IIa clinical trial for psoriasis; and APIRx-1603, which has completed Phase IIa clinical trial for atopic dermatitis. In addition, its product portfolio includes IHL-675A for inflammatory lung disease, IHL-675A for rheumatoid arthritis, IHL-675A for inflammatory bowel disease, and IHL-216A for traumatic brain injury/concussion, which have completed pre-clinical trials; and MedChew 1401 for pain and spasticity in multiple sclerosis, MedChew GB for post-herpatic neuralgia, MedChew-1502 for Parkinson's disease, MedChew-1503 for dementia, MedChew RL for restless legs syndrome, APIRx 1505 Flotex for chrohn's disease, CanChew RX and SuppoCan (Suppository) for inflammatory bowel disease, CheWell for addiction of cannabis, CanQuit for tobacco smoking cessation, CanQuit O for opioid addiction, APIRx-1701 for glaucoma, and APIRx-1702 for dry eye syndrome that are in pre-clinical trials. The company was formerly known as Impression Healthcare Limited and changed its name to Incannex Healthcare Limited in June 2020. Incannex Healthcare Limited was incorporated in 2001 and is based in Melbourne, Australia. .

Frequently asked questions

What percentage of Incannex Healthcare is owned by institutions?
Currently 0.005% of Incannex Healthcare shares are held by institutions.
When does the fiscal year end for Incannex Healthcare?
Incannex Healthcare's fiscal year ends in June.
Where is Incannex Healthcare based?
Incannex Healthcare's address is: 105/8 Century Circuit, Sydney, NSW, Australia, 2153
What is Incannex Healthcare's ISIN number?
Incannex Healthcare's international securities identification number is: US45333L1061

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site